Amino-terminal B-natriuretic peptide levels and postablation recurrence in hypertensive patients with paroxysmal atrial fibrillation

Heart Rhythm

Volumn 12, Issue 7, 2015, Pages 1470-1475

  Giannopoulos, Georgios ^a,c   Kossyvakis, Charalampos ^a   Angelidis, Christos ^a   Efremidis, Michael ^b   Panagopoulou, Vasiliki ^c   Letsas, Konstantinos ^b   Bouras, Georgios ^a   Vassilikos, Vassilios P ^d   Goudevenos, John ^e   Tousoulis, Dimitrios ^c   Lekakis, John ^c   Deftereos, Spyridon ^c  

^a G GENNIMATAS GENERAL HOSPITAL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

^c UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^d AHEPA UNIVERSITY HOSPITAL   (Greece)

^e UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Amino terminal fragment of brain type natriuretic peptide; Brain type natriuretic peptide; Pulmonary vein isolation; Radiofrequency ablation

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

ADULT; ARTICLE; FEMALE; FOLLOW UP; HEART LEFT ATRIUM; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PAROXYSMAL ATRIAL FIBRILLATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY VEIN ISOLATION; RADIOFREQUENCY ABLATION; RECURRENCE RISK; RECURRENT DISEASE; ADVERSE EFFECTS; AGED; ATRIAL FIBRILLATION; BLOOD; CATHETER ABLATION; COMPLICATION; CONTROLLED STUDY; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROCEDURES; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; PULMONARY VEIN; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR;

AGED; ATRIAL FIBRILLATION; BIOMARKERS; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY VEINS; RECURRENCE; RISK ASSESSMENT; RISK FACTORS;

EID: 84937513377     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2015.04.002     Document Type: Article

References (19)

1. A. Luchner, T.L. Stevens, D.D. Borgeson, M. Redfield, C.M. Wei, J.G. Porter, and J.C. Burnett Jr Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure Am J Physiol 274 1998 H1684 H1689
2. T.J. Wang, M.G. Larson, D. Levy, E.J. Benjamin, E.P. Leip, T. Omland, P.A. Wolf, and R.S. Vasan Plasma natriuretic peptide levels and the risk of cardiovascular events and death N Engl J Med 350 2004 655 663
3. V. Panagopoulou, S. Deftereos, C. Kossyvakis, K. Raisakis, G. Giannopoulos, G. Bouras, V. Pyrgakis, and M.W. Cleman NTproBNP: an important biomarker in cardiac diseases Curr Top Med Chem 13 2013 82 94
4. A. Hammerer-Lercher, B. Puschendorf, and J. Mair Cardiac natriuretic peptides: new laboratory parameters in heart failure patients Clin Lab 47 2001 265 277
5. C.J. Pemberton, M.L. Johnson, T.G. Yandle, and E.A. Espiner Deconvolution analysis of cardiac natriuretic peptides during acute volume overload Hypertension 36 2000 355 359
6. L.S. Wann, A.B. Curtis, C.T. January, K.A. Ellenbogen, J.E. Lowe, N.A. Estes 3rd, R.L. Page, M.D. Ezekowitz, D.J. Slotwiner, W.M. Jackman, W.G. Stevenson, and C.M. Tracy 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Heart Rhythm 8 2011 157 176
7. A.A. Hussein, W.I. Saliba, D.O. Martin, and et al. Plasma B-type natriuretic peptide levels and recurrent arrhythmia after successful ablation of lone atrial fibrillation Circulation 123 2011 2077 2082
8. D.W. den Uijl, V. Delgado, L.F. Tops, A.C. Ng, E. Boersma, S.A. Trines, K. Zeppenfeld, M.J. Schalij, A. van der Laarse, and J.J. Bax Natriuretic peptide levels predict recurrence of atrial fibrillation after radiofrequency catheter ablation Am Heart J 161 2011 197 203
9. J. Fan, H. Cao, L. Su, Z. Ling, Z. Liu, X. Lan, Y. Xu, W. Chen, and Y. Yin NT-proBNP but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation J Interv Card Electrophysiol 33 2012 93 100
10. H.J. Hwang, J.W. Son, B.H. Nam, B. Joung, B. Lee, J.B. Kim, M.H. Lee, Y. Jang, N. Chung, W.H. Shim, S.Y. Cho, and S.S. Kim Incremental predictive value of pre-procedural N-terminal pro-B-type natriuretic peptide for short-term recurrence in atrial fibrillation ablation Clin Res Cardiol 98 2009 213 218
11. G. Giannopoulos, C. Kossyvakis, M. Efremidis, and et al. Central sympathetic inhibition to reduce postablation atrial fibrillation recurrences in hypertensive patients: a randomized, controlled study Circulation 130 2014 1346 1352
12. D.C. Plitt, E.H. Chung, J.P. Mounsey, J.D. Schwartz, I.W. Pursell, and A.K. Gehi Relation of atrial fibrillation burden and N-terminal pro-brain natriuretic peptide Am J Cardiol 111 2013 1315 1318
13. B. Nilsson, J.P. Goetze, X. Chen, S. Pehrson, and J.H. Svendsen Increased NT-pro-B-type natriuretic peptide independently predicts outcome following catheter ablation of atrial fibrillation Scand J Clin Lab Invest 69 2009 843 850
14. A. Pedrote, E. Arana-Rueda, L. García-Riesco, J. Sánchez-Brotons, M. Durán-Guerrero, F. Gómez-Pulido, A. Arce-León, and M. Frutos-López Paroxysmal atrial fibrillation burden before and after pulmonary veins isolation: an observational study through a subcutaneous leadless cardiac monitor J Cardiovasc Electrophysiol 24 2013 1075 1082
15. J. Dewire, I.M. Khurram, F. Pashakhanloo, D. Spragg, J.E. Marine, R.D. Berger, H. Ashikaga, J. Rickard, S.L. Zimmerman, V. Zipunnikov, H. Calkins, and S. Nazarian The association of pre-existing left atrial fibrosis with clinical variables in patients referred for catheter ablation of atrial fibrillation Clin Med Insights Cardiol 8 2014 25 30
16. P.T. Ellinor, A.F. Low, K.K. Patton, M.A. Shea, and C.A. Macrae Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation J Am Coll Cardiol 45 2005 82 86
17. S. Deftereos, G. Giannopoulos, C. Kossyvakis, K. Raisakis, A. Theodorakis, A. Kaoukis, K. Toli, V. Panagopoulou, M. Driva, I. Mantas, V. Pyrgakis, and M.A. Alpert Short-term fluctuations of plasma NT-proBNP levels in patients with new-onset atrial fibrillation: a way to assess time of onset? Heart 96 2010 1033 1036
18. S. Deftereos, G. Giannopoulos, C. Kossyvakis, and et al. Estimation of atrial fibrillation recency of onset and safety of cardioversion using NTproBNP levels in patients with unknown time of onset Heart 97 2011 914 917
19. A. Berkowitsch, T. Neumann, M. Kuniss, R. Brandt, S. Zaltsberg, and H.F. Pitschner Evaluation of atrial fibrillation burden before catheter ablation predicts outcome after pulmonary vein isolation Indian Pacing Electrophysiol J 9 2009 138 150